• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Meet OMF's New Scientific Advisory Board Members

Ben H

OMF Volunteer Correspondent
Messages
1,131
Location
U.K.
Hi guys,

More good news:

Tocq_jpLnd-dCvxKHzsxwmvp0QJ_hAFqJKB1Bl-Ek0kLzjzQyBcJCsus1E99yTjkwYjs67JX6_9RcOfHiwuQhHKrn6PD6Yc5o4nZlkbVA7NkfKNwws0ueEF_tsZrtL2nREnorGCgOzFGBQlxZtwZJp7oha3vAh4Xf0UZeyVnJNj1NN_zTKflEXYlkGEgyshDBEpSvpk8hbPaiWA=s0-d-e1-ft

Jennifer Frankovich, MD, Daniel Peterson, MD, &
Michael Snyder, PhD, Join OMF's Scientific Advisory Board

Dear friends,

We are delighted to announce the addition of three leading researchers to OMF's Scientific Advisory Board. Jennifer Frankovich, MD, has experience in autoimmunity and post-infectious inflammatory diseases. Daniel Peterson, MD, is a recognized medical expert in ME/CFS. Michael Snyder, PhD, a leader in the field of functional genomics and proteomics.

Our research team is working collaboratively and openly to find answers. Please join us in welcoming the newest members of our team.

WzhEVuH2jVoi86ouvP3ECc3_kTd7Tq49ZhB89Rz2_1CsrXEWCHR6Dm15Igg8NbGwWENPjLSaW3Ur9E0lIGNr_8PMW9IArc61LQpADe7NWJp-TNzoei4WyZirvA8yYd_9LPsh9aEF-ef-3q5B5iQ18mU=s0-d-e1-ft


With hope for all,

glA7cZmKjDbmh8TnrHaSrm1FZDRa0RhY0xQcMxAF8Os0eEHuYTRlu_G8kRra2BswFPsiY45lamM20X3iGGN7oRIAcLtMqNgBpyvpL0wjqAYweDqypfsGq9dLETXDcfEpSgnWKIg=s0-d-e1-ft

Linda Tannenbaum
Founder & CEO/President


Jennifer Frankovich, MD
QTVFHpILbYYDaXvgB8UfOfWItDLT6p8Z6962QiNEP0lVju8J6KTUgP4Inv8Zfu5T7sX6IQQavOPODyod21b3tV7dJkybhhnFH2yl1ZvFGsOwTANxq4O6Ihn8DdGB1iE8kYg=s0-d-e1-ft


Jennifer Frankovich, MD, is a pediatric rheumatologist in California and is an expert in systemic autoimmune and post-infectious inflammatory diseases that affect the brain and specializes in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)/ Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS). Dr. Frankovich is the PANS Program Director at Stanford Children's Hospital and an Associate Professor in Pediatrics and Pediatric Rheumatology at Stanford School of Medicine. Dr. Frankovich’s clinical experience in autoimmunity and post-infectious inflammatory diseases are highly relevant as ME/CFS is thought to have an autoimmune component that might manifest after symptoms of an infection.

Dr. Frankovich received her MD from the University of Nevada School of Medicine and completed her residency and fellowship at Stanford University.

Daniel L. Peterson, MD
RRK_z_-ofUL30wNx3g2K6x6D3wgNAQe_aaPGtv7Z9HKE_5WwVDBu8qN0jEMv3kSVQKZYz1PkstujJv2k6GdJJOdPtqMJPCrbBhaZSrKeIwe1Ku_9j8PnFxqiIg=s0-d-e1-ft


Daniel L. Peterson, MD, is an internist in Incline Village, Nevada and recognized medical expert on ME/CFS. Dr. Peterson has devoted more than 25 years of his clinical career to diagnosing and caring for patients with ME/CFS and related neuroimmune disorders, as well as collaborating with researchers to better understand the illness. Dr. Peterson’s experience as both a clinician and a research collaborator provide a unique perspective on ME/CFS for developing translational science.
Dr. Peterson’s interest in ME/CFS began in 1984 when Incline Village became the site of an unusual cluster of individuals presenting with unexplained flu-like symptoms that would not go away. Many of those individuals remained bedridden for extended periods of time. Dr. Peterson was perhaps the first to recognize these symptoms as something deserving of more attention.

Dr. Peterson received his MD from the University of Rochester School of Medicine, Rochester, NY, and completed his internship and residency at the University of Utah Medical Center.

Michael Snyder, PhD
ecOip6wTDTN5FD0UelfLPR5WD3scBbNpgq8w4ULmnZSIEjTXVL7oTMh3IQ7kvKlG_Y28q64zq97gR89xHn1tVJXY0QwmqQqaF99k_uTdVQ39kj2o3cc29Pmyrf9aD2mjYIXj=s0-d-e1-ft

Michael Snyder, PhD, is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated, and a high diversity of transcription factor binding occurs both between and within species. He has also pioneered the use of different state-of-the-art "omics" technologies as well as wearable devices (smart watches and continuous glucose monitoring) for managing human health. Dr. Synder’s expertise in “omic” and wearable technologies will be invaluable in both current and future ME/CFS research efforts.

Dr. Snyder is the Stanford W. Ascherman Professor and Chair, Department of Genetics and Director, Center for Genomics and Personalized Medicine at Stanford University. Dr. Snyder received his PhD at the California Institute of Technology and carried out his postdoctoral training at Stanford University.

Donate now to support ground-breaking research.


www.omf.ngo



@Janet Dafoe (Rose49) @marilynbsg @​